Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factors

THERAPEUTIC VACCINE TARGETED AGAINST P-GLYCOPROTEIN 170 FOR INHIBITING MULTIDRUG RESISTANCE IN THE TREATMENT OF CANCERS

Intradermal cellular delivery using narrow gauge micro-cannula

Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin

Methods and compositions to treat and detect misfolded-SOD1 mediated diseases

Method of treating a patient having an autoimmune disorder by administering an antibody that binds human BAFFR

Heparanase-derived peptides for vaccination of tumor patients

Medical Uses of Carrier Conjugates of Non-Human Tnf -Peptides

Methods for using OX-40 ligand to enhance an antigen specific immune response

Edible vaccines expressed in soybeans

Method of administering porcine B-domainless fVIII

Allergy inhibitor compositions and kits and methods of using the same

Molecular antigen arrays

Inactivated CD8+ T-cells for the treatment of HIV infection

Antigen arrays for treatment of bone disease

Method for the production of an immunostimulating mucin (muc1)

Antigen arrays for treatment of allergic eosinophilic diseases

Angiotensin peptide-carrier conjugates and uses thereof

Liposomal vaccine

Liposomal vaccine

DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof

Molecular antigen array

Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity

Methods for genetic immunization

Modulation of cholesteryl ester transfer protein (CETP) activity

Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases

Modified t lymphocytes and uses therefor

Method for treatment of malignant and infectious chronic diseases

Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers

Detoxified TNF and method of preparing

MHC CLASS II AS A PREVENTIVE VACCINE AGAINST HIV INFECTION

Treatment for renal disease

Novel inhibin-related multiple antigenic peptide compositions that enhance production performance in avians

Vaccine composition comprising interleukin-15 (IL-15)

Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin

Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use

Combination treatment of pancreatic cancer

Albumin-fused anti-angiogenesis peptides

Protective immunity or immunological tolerance induced with RNA, particularly total cellular RNA

Allogeneic cellular immunotherapy for opportunistic infection

Vaccine composition comprising methylated DNA and immunomodulatory motifs

Vaccine comprising il-13 and an adjuvant

Depletion of endogenous primordial germ cells in avian species

Use of passive myostatin immunization in egg laying vertebrates

Methods for the prevention against or treatment of diabetes with ETXB and/or insulin

Antigen-presenting complex-binding compositions and uses thereof

Angiotensin peptide-carrier conjugates and uses thereof

Vaccine against infectious agents having an intracellular phase, composition for the treatment and prevention of HIV infections, antibodies and method of diagnosis

Stable immunogenic product comprising antigenic heterocomplexes

Induction of cytotoxic T-lymphocyte responses

Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent

Vaccine for hair removal

Vaccines for suppressing ige-mediated allergic disease and methods for using the same

Method for the treatment of gastroesophageal reflux disease

Method for tumor treatment using infusion of xenogeneic cells to induce hyperacute rejection and innocent bystander effect

Method for preparing a stable TNF-α vaccine

Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins

Novel therapeutic processes for treating infectious agents using same epitope specific antigens, and useful compositions therefor

Neutralizing antibodies and methods of use thereof

Novel therapeutic processes for treating cancer with trained or adopted immune cells, and useful compositions therefor

Vaccines absorbable by the transmucosal way

Novel therapeutic processes for treating cancer with specific antigens

Novel therapeutic processes for treating infectious agents by training or adoptive transfer of immune cells, and useful compositions therefor

Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers

Novel therapeutic processes for enhancing immunized states of vaccinated subjects

Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers

Intradermal cellular delivery using narrow gauge micro-cannula

Treatment of cancers

Treatment and prevention of viral hepatitis infections

Compounds for eliciting or enhancing immune reactivity to HER-2/protein for prevention or treatment of malignancies in which the HER-2/oncogene is associated

Novel application of vaccination against TNF-alpha

Active antiangiogenic therapy

Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers

Methods for recovering peptides from stress protein-peptide complexes

Treatment and prevention of HIV and other viral infections

Autogenous vaccine derived from one's own hypothalamus of the brain & kidney's via a process known as liquefaction

Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs

Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof

Treatment and prevention of HIV and other viral infections

Therapeutic processes and useful compositions therefor

Novel therapeutic vaccination processes, and useful compositions therefor

Novel therapeutic processes for establishing or enhancing an immunized state, and compositions useful therefor

Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease

Altering A B cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent

Antigen presenting vesicles

PTH-rP related peptide cancer therapeutics

Cationic lipid-mediated enhancement of nucleic acid immunization of cats

Methods of prevention and treatment of asthma, and allergic conditions

Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs

Methods of prevention and treatment of asthama, and allergic conditions

Methods of prevention and treatment of asthma, and allergic conditions

Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease

Composition for treating or preventing insulin resistance

Immunogenic compositions comprising nucleic acids for RAS peptides

Combination therapies for the treatment of Alzheimer's disease and related disorders

Methods and compositions for treating osteoarthritis

Reversibly crosslinked endosomolytic polymer vesicles for cytosolic drug delivery